Evidence map›Paper›PMID 40560960›Full record

ArticlePloS one2025

Evaluation of sugar meal administered anti-Leishmania compounds on the vectorial capacity of the vector, Lutzomyia longipalpis.

Tainá Neves Ferreira, Samara Graciane Costa Latgé, Tadeu Diniz Ramos, Felipe Cerqueira Demidoff, Edézio Ferreira Cunha-Júnior, Paulo Roberto Ribeiro Costa, Marcus Vinícius Nora de Souza, Cláudia Regina Brandão Gomes, Viv Maureen Dillon, Chaquip Daher Netto and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tainá Neves FerreiraLaboratório de Bioquímica e Fisiologia de Insetos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Samara Graciane Costa LatgéLaboratório de Bioquímica e Fisiologia de Insetos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Tadeu Diniz RamosLaboratório de Imunobiotecnologia IMPG, Universidade Federal do Rio de Janeiro/ Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Felipe Cerqueira DemidoffLaboratório Multiusuário de Pesquisa em Química, Instituto Multidisciplinar de Química, CM UFRJ-Macaé, Universidade Federal do Rio de Janeiro, Macaé, Brazil.ORCID 0000-0001-6782-4440
Edézio Ferreira Cunha-JúniorLaboratório de Imunoparasitologia, Unidade Integrada de Pesquisa em Produtos Bioativos e Biociências, Universidade Federal do Rio de Janeiro, UFRJ-Macaé Campus, Macaé, Brazil.
Paulo Roberto Ribeiro CostaLaboratório de Química Bioorgânica, Instituto de Pesquisa em Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Marcus Vinícius Nora de SouzaDepartamento de Síntese de Fármacos, Farmanguinhos, Fiocruz, Rio de Janeiro, Brazil.
Cláudia Regina Brandão GomesDepartamento de Síntese de Fármacos, Farmanguinhos, Fiocruz, Rio de Janeiro, Brazil.
Viv Maureen DillonFaculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.
Chaquip Daher NettoLaboratório Multiusuário de Pesquisa em Química, Instituto Multidisciplinar de Química, CM UFRJ-Macaé, Universidade Federal do Rio de Janeiro, Macaé, Brazil.
Eduardo Caio Torres SantosLaboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Rod James DillonBiomedical and Life Sciences, Lancaster University, Lancaster, United Kingdom.
Mary Ann McDowellEck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.
Herbert Leonel de Matos GuedesLaboratório de Imunobiotecnologia IMPG, Universidade Federal do Rio de Janeiro/ Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Fernando Ariel GentaLaboratório de Bioquímica e Fisiologia de Insetos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.ORCID 0000-0001-9558-1116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple strategies involving the parasite-host-vector triad are necessary to control leishmaniasis. One option is to prevent or reduce transmission of the pathogen by the phlebotomine sand fly vectors. In this sense, it is essential to explore compounds that may influence the vectorial capacity of the insect and reduce its longevity. We investigated the effect of anti-Leishmania drugs administered via the sugar meal on longevity, blood feeding, oviposition, and parasite load on the third day of infection of the sand flies, to identify the most promising candidates for vector infection tests. We identified compounds that affected the longevity of sand flies (three pterocarpanquinones - LQB-475, LQB-181, and LQ-03; one hydroxyethylpiperazine, PMIC-4, and Pentamidine), reduced oviposition of females after blood feeding (LQB-181 and PMIC-4), but did not decrease infection rates or parasite loads. The results provide the effect of antiparasitic drugs from the perspective of the insect vector.

Indexed as

Antiprotozoal AgentsInsect VectorsLeishmaniaPsychodidaeSugarsAnimalsFeeding BehaviorFemaleLeishmaniasisLongevityOvipositionAntiprotozoal AgentsSugars

Identifiers

PMID40560960
PMCPMC12194183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.